AVANIR Pharmaceuticals (NASDAQ:AVNR)
| CAPS Rating |
|
|---|---|
| Open | $2.99 |
| Previous Close | $3.03 |
| Daily Range | $2.92 - $3.03 |
| 52-Week Range | $1.77 - $4.80 |
| Market Cap | $363.87M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,029,258 |
| Average Daily Volume | 0 |
AVNR
VS S&P 500 (SPY)
How do you think AVNR will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AVNR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AVNR News and Commentary
- The Dow's Run Is Not Done – The Motley Fool
- Is Avanir Pharmaceuticals the Perfect Stock? – The Motley Fool
- These 5 Companies Have Dominated 2012 – The Motley Fool
- The Worst Health-Care Stocks of 2011 – The Motley Fool
- You've Got 4 Days Left to Do This – The Motley Fool
- A No-Good, Really Bad, Awful Year for This Pharmaceutical Company – The Motley Fool
- 1 Massive Biotech Bloodbath – The Motley Fool
- 3 Biotechs Making Big Moves on Big News – The Motley Fool
- 7 Reasons to Worry About Next Week – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- 5 Biotechs Posting Big Gains – The Motley Fool
- 7 Black Friday Biotech Bargains – The Motley Fool
- 7 Reasons to Worry About Next Week – The Motley Fool
- Modest Growth, Less-Than-Modest Stock Drop – The Motley Fool
- After Hours: Dendreon's Shares Crushed Again – The Motley Fool
- Invest in Biotechs Going After Unmet Needs – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Tuesday Night Watchlist – Blog at The Motley Fool
- These Sales Matter Most – The Motley Fool
- Should You Get Out of Forest Laboratories Before Next Quarter? – The Motley Fool
RSS Headlines
Fool UK
